Synergistic fusion of CD47, VE-cadherin and mussel adhesion protein promotes endothelialization and suppresses inflammation in vascular stents
Source abstract
Abstract
Endothelial cell (EC)-specific coatings for vascular stents are crucial for enhancing their biocompatibility and preventing complications such as restenosis and thrombosis. This study developed an innovative CD47-VE-cadherin-Mfp5 (CD47-VE-M) fusion protein coating for cardiovascular stents that integrates three distinct functional domains: endothelial adhesion enhancement (VE-cadherin EC1-2), macrophage inhibitory signaling (CD47), and substrate adhesion reinforcement (Mfp5). In vitro , CD47-VE-M coatings significantly promoted EC adhesion (3.4-fold increase vs. bare-metal stent (BMS) (p < 0.001)), directional migration (accelerated 62 % compared to BMS at 24 h) and proliferation (2.3-fold increase vs. BMS (p < 0.01)), with increased VE-cadherin expression and improved tight junction formation (1.5-fold higher than BMS (p < 0.001)). Additionally, the CD47-VE-M coating reduced macrophage phagocytosis by 59 % (p < 0.01). Compared with BMS, synergistic CD47-VE-M fusion protein-coated stents showed accelerated endothelialization and reduced neointimal hyperplasia and restenosis by 64.4 % (p < 0.001) in vivo . Besides, the coating also decreased the presence of M1 pro-inflammatory macrophages (64.74 % decrease vs. BMS (p < 0.01)), which mitigated the inflammatory response. This novel coating strategy overcomes the limitations of current drug-eluting stent (DES) by simultaneously enhancing endothelial regeneration and suppressing pathological inflammation. Synergistic integration of CD47, VE-Cadherin, and mussel adhesion protein enhances endothelialization and attenuates inflammatory responses in vascular stents. • CD47-VE-Cadherin-Mfp-5 (CD47-VE-M) fusion protein was synthesized for the first time. • CD47-VE-M coatings promote endothelial repair, suppress macrophage phagocytosis in vitro. • Dual-functional stent accelerates endothelialization and reduces restenosis in vivo.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Phagocytosis and Immune Regulation · Cell Adhesion Molecules Research · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease10.1056/NEJMoa2305637 ↗
2. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium10.1161/CIRCULATIONAHA.123.064473 ↗
3. Anti-Atherosclerotic therapies: milestones, challenges, and emerging innovations10.1016/j.ymthe.2022.08.024 ↗
4. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside10.1093/cvr/cvac105 ↗
5. A drug-free cardiovascular stent functionalized with tailored collagen supports in-Situ healing of vascular tissues10.1038/s41467-024-44902-2 ↗
6. A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by Cgmp-Pkg and Nf-Kappa B signaling pathways10.1016/j.biomaterials.2023.122288 ↗
7. Randomized comparison of novel low-dose sirolimus-eluting biodegradable polymer stent Vs second-generation des: Target-IV Na trial10.1016/j.jacc.2024.10.074 ↗
8. Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in St-Segment elevation myocardial infarction: 5-year Follow-Up of the biostemi randomised superiority trial10.1016/S0140-6736(23)02197-9 ↗
9. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment10.1016/S1474-4422(21)00376-8 ↗
10. An integrated arterial remodeling hydrogel for preventing restenosis after angioplasty10.1002/advs.202307063 ↗
11. Polyphenol-network-mediated coating modulates inflammation and vascular healing on vascular stents10.1021/acsnano.2c00642 ↗
12. Biliary stents for active materials and surface modification: recent advances and future perspectives
13. "Built-Up" composite film with synergistic functionalities on Mg-2Zn-1Mn bioresorbable stents improves corrosion control effects and biocompatibility
14. Biosafety and efficacy evaluation of a biodegradable zn-cu-mn stent: a long-term study in porcine coronary artery
15. Mussel adhesive protein fused with Ve-Cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent10.1002/jbm.b.34369 ↗
16. Timp2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting src-dependent Ve-Cadherin internalization10.1172/JCI164199 ↗
17. Vascular Flrt2 regulates venous-mediated angiogenic expansion and cns barriergenesis10.1038/s41467-024-54570-x ↗
18. Ubiquitin ligase chfr mediated degradation of Ve-Cadherin through ubiquitylation disrupts endothelial adherens junctions10.1038/s41467-023-42225-2 ↗
19. Crosstalk between adenosine receptors and Cyp450-Derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response10.1016/j.pharmthera.2022.108213 ↗
20. Coronary stent Cd31-Mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo10.1093/eurheartj/ehab027 ↗
21. Baicalin-based composite coating for achieving biological multifunctionality of vascular stents10.1016/j.jconrel.2025.01.005 ↗
22. A self-sacrificing anti-inflammatory coating promotes simultaneous cardiovascular repair and reendothelialization of implanted devices
23. Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of Cd47 "Don't Eat Me" Ssgnals10.1158/1078-0432.CCR-14-2520 ↗
24. Increase in charge and density improves the strength and toughness of mussel foot protein 5 inspired protein materials10.1021/acsbiomaterials.3c00088 ↗
25. A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintenance10.1016/j.biomaterials.2024.122751 ↗
26. Bi-Terminal fusion of intrinsically-disordered mussel foot protein fragments boosts mechanical strength for protein fibers10.1038/s41467-023-37563-0 ↗
27. Mytilus Edulis foot protein mimics for tailoring long-acting endothelium-mimicking anti-thrombotic surfaces
28. Aspirin plus Rivaroxaban versus Rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: the multicenter, multinational, randomized, open-label ariva trial10.1161/CIRCULATIONAHA.124.073050 ↗
29. Optical coherence tomography predictors of clinical outcomes after stent implantation: the ilumien IV trial10.1093/eurheartj/ehae521 ↗
30. M2 macrophage-derived exosomes promote the C-Kit phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation10.7150/thno.46143 ↗
31. A high-performance chitosan-grafted Cu(Ⅱ) coating improves endothelialization and mitigates the degradation of biodegradable magnesium alloy stents10.1016/j.biomaterials.2025.123161 ↗
32. Gas station in blood vessels: an endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis10.1016/j.biomaterials.2023.122311 ↗
33. Engineered endothelium model enables recapitulation of vascular function and early atherosclerosis development10.1016/j.biomaterials.2024.122889 ↗
34. Ve-Cadherin endocytosis controls vascular integrity and patterning during development10.1083/jcb.201909081 ↗
35. "Synergistic Anticoagulant and Endothelial Regeneration Strategy" based on mussel-inspired phospholipid copolymer coating and Bioactive zeolitic imidazolate Frameworks-90 to maintain the patency of cocr stent
36. Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis10.1093/eurheartj/ehac647 ↗
37. Synthesis and characterization of amine-functionalized graphene as a nitric oxide-generating coating for vascular stents10.1063/5.0192379 ↗
38. Ccn5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin Β4 and Cd9 pathway10.1093/eurheartj/ehae911 ↗
39. Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis10.7150/thno.103747 ↗
40. Mechanical and physio-biological properties of peptide-coated stent for Re-Endothelialization10.1186/s40824-020-0182-x ↗
41. Biomimetic ros-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis10.1093/rb/rbae102 ↗
42. Plx3397, a Csf1 receptor inhibitor, limits allotransplantation-induced vascular remodelling10.1093/cvr/cvab289 ↗
43. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing10.1016/j.actbio.2024.02.022 ↗
44. Senescent endothelial cells' response to the degradation of bioresorbable scaffold induces intimal dysfunction accelerating in-Stent restenosis10.1016/j.actbio.2023.05.028 ↗
45. Riding a vascular time train to spatiotemporally attenuate thrombosis and restenosis by double presentation of therapeutic gas and biomacromolecules
46. Co-Loaded Hemoglobin/Egcg nanoparticles functional coatings for inflammation modulation of vascular implants10.1093/rb/rbae148 ↗
47. Versatile effects of Galectin-1 protein-containing lipid bilayer coating for cardiovascular applications
48. First-in-Human phase I trial of the bispecific Cd47 inhibitor and Cd40 agonist Fc-Fusion protein, Sl-172154 in patients with platinum-resistant ovarian cancer10.1136/jitc-2024-010565 ↗
49. Sirpalpha-Fc fusion protein Imm01 exhibits dual anti-tumor activities by targeting Cd47/Sirpalpha signal pathway via blocking the "Don't Eat Me" Signal and Activating the "Eat Me" Ssgnal10.1186/s13045-022-01385-2 ↗
50. Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces
51. A facile metal-phenolic-amine strategy for dual-functionalization of blood-contacting devices with antibacterial and anticoagulant properties10.1039/C8QM00458G ↗
52. A versatile surface bioengineering strategy based on mussel-inspired and bioclickable peptide mimic
53. Endothelium-mimicking multifunctional coating modified cardiovascular stents via a stepwise Metal-Catechol-(Amine) surface engineering strategy
54. Bio-inspired lotus-fiber and mussel-based multifunctional hydrogels for wound healing: super-stretchability, self-healing, adhesion and antibacterial properties10.1093/rb/rbaf031 ↗
55. Lithium-induced optimization mechanism for an ultrathin-strut biodegradable Zn-Based vascular scaffold10.1002/adma.202301074 ↗
56. Additive manufacturing of biodegradable molybdenum - from powder to vascular stent10.1002/adma.202401614 ↗
57. Incorporating copper to biodegradable magnesium alloy vascular stents via a Cu(II)‐Eluting coating for synergistic enhancement in prolonged durability and rapid re‐endothelialization
58. Mussel-inspired Dopamine-Cu II coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis10.1016/j.biomaterials.2018.12.020 ↗
59. Spatiotemporal dual-delivery of therapeutic gas and growth factor for prevention of vascular stent thrombosis and restenosis
60. Hierarchical capillary coating to biofunctionlize drug-eluting stent for improving endothelium regeneration
61. Peptide vaccine against Adamts-7 ameliorates atherosclerosis and postinjury Neointima Hyperplasia10.1161/CIRCULATIONAHA.122.061516 ↗
62. In situ H2 S-Releasing stents optimize vascular healing10.1021/acsnano.4c16345 ↗
63. Structural and temporal dynamics analysis on drug-eluting stents: history, research hotspots and emerging trends
64. Structural and temporal dynamics analysis of zinc-based biomaterials: history, research hotspots and emerging trends